rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2002-6-14
|
pubmed:abstractText |
The oral combined formulation of levonorgestrel with estradiol valerate (LNG+EV) has demonstrated to be effective on some postmenopausal symptoms. The availability of a transdermal HRT in sequential formulation with 17-beta-estradiol plus levonorgestrel (TSE2+TSLNG) induced us to do this control-study with the aim to evaluate the efficacy and safety of both oral and transdermal treatments.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0378-5122
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-47
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12065173-Administration, Cutaneous,
pubmed-meshheading:12065173-Administration, Oral,
pubmed-meshheading:12065173-Bone Resorption,
pubmed-meshheading:12065173-Estradiol,
pubmed-meshheading:12065173-Estrogens, Conjugated (USP),
pubmed-meshheading:12065173-Female,
pubmed-meshheading:12065173-Glucose Tolerance Test,
pubmed-meshheading:12065173-Hormone Replacement Therapy,
pubmed-meshheading:12065173-Humans,
pubmed-meshheading:12065173-Insulin,
pubmed-meshheading:12065173-Levonorgestrel,
pubmed-meshheading:12065173-Middle Aged,
pubmed-meshheading:12065173-Postmenopause,
pubmed-meshheading:12065173-Progesterone Congeners
|
pubmed:year |
2002
|
pubmed:articleTitle |
Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel.
|
pubmed:affiliation |
Clinica Ginecologica Ostetrica e di Fisiopatologia della Riproduzione Umana del Dipartimento Chirurgico Materno-Infantile e di Scienze delle Immagini, Università degli Studi di Cagliari, Via Ospedale 46, 09124, Cagliari, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|